The pharmokinetic limitations of antioxidant treatment for COPD

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 2, 2008, Pages 370-379

  Foronjy, Robert ^a   Wallace, Alison ^a   D'Armiento, Jeanine ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Antioxidants; Bioavailability; Chronic obstructive pulmonary disease; Cigarette smoke; Emphysema; Inflammation

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA CAROTENE; CAROTENOID; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIGARETTE SMOKE; CORTICOSTEROID; FLAVANOID; FLAVANOL DERIVATIVE; FLAVONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; PLACEBO; RESVERATROL; SALMETEROL; SELENIUM; TIOTROPIUM BROMIDE; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DETERIORATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; HEALTH STATUS; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; SIGNAL TRANSDUCTION; THERAPY EFFECT; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39749151005     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.10.004     Document Type: Article

References (112)

1. Coultas D.B., Mapel D., Gagnon R., and Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 164 (2001) 372-377
2. Jemal A., Ward E., Hao Y., and Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 294 (2005) 1255-1259
3. Michaud C.M., Murray C.J., and Bloom B.R. Burden of disease implications for future research. JAMA 285 (2001) 535-539
4. Sullivan S., Ramsey S., and Lee T. The economic burden of COPD. Chest 117 Suppl. (2000) 5S-9S
5. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
6. Tashkin D.P., and Cooper C.B. The role of long-acting bronchodilators in the management of stable COPD. Chest 125 (2004) 249-259
7. Donohue J.F., Menjoge S., and Kesten S. Tolerance to bronchodilating effects of salmeterol in COPD. Respir Med 97 (2003) 1014-1020
8. Brusasco V., Hodder R., Miravitlles M., Korducki L., Towse L., and Kesten S. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 58 (2003) 399-404
9. Calverley P.M., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 (2007) 775-789
10. Alsaeedi A., Sin D.D., and McAlister F.A. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 113 (2002) 59-65
11. Barnes N.C., Qiu Y.S., Pavord I.D., Parker D., Davis P.A., Zhu J., et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med 173 (2006) 736-743
12. Vestbo J., Sorensen T., Lange P., Brix A., Torre P., and Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 353 (1999) 1819-1823
13. Culpitt S.V., Maziak W., Loukidis S., Nightingale J.A., Matthews J.L., and Barnes P.J. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1635-1639
14. Loppow D., Schleiss M.B., Kanniess F., Taube C., Jorres R.A., and Magnussen H. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med 95 (2001) 115-121
15. Zheng T., Kang M.J., Crothers K., Zhu Z., Liu W., Lee C.G., et al. Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema. J Immunol 174 (2005) 8106-8115
16. Imai K., Mercer B.A., Schulman L.L., Sonett J.R., and D'Armiento J.M. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J 25 (2005) 250-258
17. Pryor W.A., Prier D.G., and Church D.F. Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect 47 (1983) 345-355
18. Igishi T., Hitsuda Y., Kato K., Sako T., Burioka N., Yasuda K., et al. Elevated urinary 8-hydroxydeoxyguanosine, a biomarker of oxidative stress, and lack of association with antioxidant vitamins in chronic obstructive pulmonary disease. Respirology 8 (2003) 455-460
19. Ichinose M., Sugiura H., Yamagata S., Koari A., and Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 162 (2000) 701-706
20. Rahman I., van Schadewijk A.A., Crowther A.J., Hiemstra P.S., Stolk J., MacNee W., et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 490-495
21. Hellermann G.R., Nagy S.B., Kong X., Lockey R.F., and Mohapatra S.S. Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res 3 (2002) 22
22. Syed D.N., Afaq F., Kweon M.H., Hadi N., Bhatia N., Spiegelman V.S., et al. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappa B activation in normal human bronchial epithelial cells. Oncogene 26 (2007) 673-682
23. Tuder R.M., Zhen L., Cho C.Y., Taraseviciene-Stewart L., Kasahara Y., Salvemini D., et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Resp Cell Mol Biol 29 (2003) 88-97
24. Verhoeven G.T., Wijkhuijs A.J., Hooijkaas H., Hoogsteden H.C., and Sluiter W. Effect of an inhaled glucocorticoid on reactive oxygen species production by bronchoalveolar lavage cells from smoking COPD patients. Mediators Inflamm 9 (2000) 109-113
25. Barnes P.J. Corticosteroid resistance in airway disease. Proc Am Thorac Soc 1 (2004) 264-268
26. Dempsey P.W., Doyle S.E., He J.Q., and Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 14 (2003) 193-209
27. Churg A., Dai J., Tai H., Xie C., and Wright J.L. Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 166 (2002) 849-854
28. Churg A., Wang R.D., Tai H., Wang X., Xie C., Dai J., et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med 167 (2003) 1083-1089
29. Vlahos R., Bozinovski S., Jones J.E., Powell J., Gras J., Lilja A., et al. Differential protease, innate immunity, and NF-kappa B induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 290 (2006) L931-L945
30. Kuschner W.G., D'Alessandro A., Wong H., and Blanc P.D. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 9 (1996) 1989-1994
31. Keatings V.M., Collins P.D., Scott D.M., and Barnes P.J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153 (1996) 530-534
32. Lucey E.C., Keane J., Kuang P.P., Snider G.L., and Goldstein R.H. Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1beta receptor-deficient mice. Lab Invest 82 (2002) 79-85
33. Churg A., Wang R.D., Tai H., Wang X., Xie C., and Wright J.L. Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 170 (2004) 492-498
34. D'Hulst A I., Bracke K.R., Maes T., De Bleecker J.L., Pauwels R.A., Joos G.F., et al. Role of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. Eur Respir J 28 (2006) 102-112
35. Han D., Hanawa N., Saberi B., and Kaplowitz N. Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic Biol Med 41 (2006) 627-639
36. Pantano C., Shrivastava P., McElhinney B., and Janssen-Heininger Y. Hydrogen peroxide signaling through tumor necrosis factor receptor 1 leads to selective activation of c-Jun N-terminal kinase. J Biol Chem 278 (2003) 44091-44096
37. Shen H.M., Lin Y., Choksi S., Tran J., Jin T., Chang L., et al. Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. Mol Cell Biol 24 (2004) 5914-5922
38. Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M., et al. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol Cell 2 (1998) 389-395
39. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17 (1998) 2596-2606
40. Hsieh C.C., and Papaconstantinou J. Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice. FASEB J 20 (2006) 259-268
41. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
42. Janssen-Heininger Y.M., Macara I., and Mossman B.T. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappa B: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappa B by oxidants. Am J Respir Cell Mol Biol 20 (1999) 942-952
43. Manna S.K., Mukhopadhyay A., and Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164 (2000) 6509-6519
44. Walters M.J., Paul-Clark M.J., McMaster S.K., Ito K., Adcock I.M., and Mitchell J.A. Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: implications for steroid resistance. Mol Pharmacol 68 (2005) 1343-1353
45. Macnee W., and Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) S58-S65
46. Kinnula V.L., and Crapo J.D. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 167 (2003) 1600-1619
47. Flohe L. Glutathione peroxidase. Basic Life Sci 49 (1988) 663-668
48. Beck M.A., Esworthy R.S., Ho Y.S., and Chu F.F. Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J 12 (1998) 1143-1149
49. Esworthy R.S., Aranda R., Martin M.G., Doroshow J.H., Binder S.W., and Chu F.F. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 281 (2001) G848-G855
50. Cheng W.H., Zheng X., Quimby F.R., Roneker C.A., and Lei X.G. Low levels of glutathione peroxidase 1 activity in selenium-deficient mouse liver affect c-Jun N-terminal kinase activation and p53 phosphorylation on Ser-15 in pro-oxidant-induced aponecrosis. Biochem J 370 (2003) 927-934
51. Franek W.R., Horowitz S., Stansberry L., Kazzaz J.A., Koo H.C., Li Y., et al. Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. J Biol Chem 276 (2001) 569-575
52. Liu Z.G., Hsu H., Goeddel D.V., and Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa B activation prevents cell death. Cell 87 (1996) 565-576
53. Ho Y.S., Chen C.H., Wang Y.J., Pestell R.G., Albanese C., Chen R.J., et al. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through Nfkappa B activation and cyclin D1 up-regulation. Toxicol Appl Pharmacol 205 (2005) 133-148
54. Mangelus M., Galron R., Naor Z., and Sokolovsky M. Involvement of nuclear factor-kappa B in endothelin-A-receptor-induced proliferation and inhibition of apoptosis. Cell Mol Neurobiol 21 (2001) 657-674
55. De Smaele E., Zazzeroni F., Papa S., Nguyen D.U., Jin R., Jones J., et al. Induction of gadd45beta by NF-kappa B downregulates pro-apoptotic JNK signalling. Nature 414 (2001) 308-313
56. Deng Y., Ren X., Yang L., Lin Y., and Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 115 (2003) 61-70
57. Gao M., Labuda T., Xia Y., Gallagher E., Fang D., Liu Y.C., et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306 (2004) 271-275
58. Chang L., Kamata H., Solinas G., Luo J.L., Maeda S., Venuprasad K., et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124 (2006) 601-613
59. Yamamoto K., Ichijo H., and Korsmeyer S.J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19 (1999) 8469-8478
60. Fan M., Goodwin M., Vu T., Brantley-Finley C., Gaarde W.A., and Chambers T.C. Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade. J Biol Chem 275 (2000) 29980-29985
61. Alikhani M., Alikhani Z., Raptis M., and Graves D.T. TNF-alpha in vivo stimulates apoptosis in fibroblasts through caspase-8 activation and modulates the expression of pro-apoptotic genes. J Cell Physiol 201 (2004) 341-348
62. Aggarwal S., Gollapudi S., and Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J Immunol 162 (1999) 2154-2161
63. Iocca H.A., and Isom H.C. Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytes. Am J Pathol 163 (2003) 465-476
64. Pastorino J.G., and Hoek J.B. Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. Hepatology 31 (2000) 1141-1152
65. Segura-Valdez L., Pardo A., Gaxiola M., Uhal B.D., Becerril C., and Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 117 (2000) 684-694
66. Yokohori N., Aoshiba K., and Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 125 (2004) 626-632
67. Calabrese F., Giacometti C., Beghe B., Rea F., Loy M., Zuin R., et al. Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir Res 6 (2005) 14
68. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114 (2004) 1248-1259
69. Schwartz J., and Weiss S.T. Dietary factors and their relation to respiratory symptoms. The second national health and nutrition examination survey. Am J Epidemiol 132 (1990) 67-76
70. Hu G., Zhang X., Chen J., Peto R., Campbell T.C., and Cassano P.A. Dietary vitamin C intake and lung function in rural China. Am J Epidemiol 148 (1998) 594-599
71. Hu G., and Cassano P.A. Antioxidant nutrients and pulmonary function: the third national health and nutrition examination survey (NHANES III). Am J Epidemiol 151 (2000) 975-981
72. Schunemann H.J., Grant B.J., Freudenheim J.L., Muti P., Browne R.W., Drake J.A., et al. The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med 163 (2001) 1246-1255
73. Hertog M.G., Hollman P.C., Katan M.B., and Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 20 (1993) 21-29
74. Tabak C., Arts I.C., Smit H.A., Heederik D., and Kromhout D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN study. Am J Respir Crit Care Med 164 (2001) 61-64
75. Kasielski M., and Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 95 (2001) 448-456
76. Sadowska A.M., van Overveld F.J., Gorecka D., Zdral A., Filewska M., Demkow U.A., et al. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant. Respir Med 99 (2005) 241-249
77. Olsson B., Johansson M., Gabrielsson J., and Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 34 (1988) 77-82
78. Pendyala L., and Creaven P.J. Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial. Cancer Epidemiol Biomarkers Prev 4 (1995) 245-251
79. Pela R., Calcagni A.M., Subiaco S., Isidori P., Tubaldi A., and Sanguinetti C.M. N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD. Respiration 66 (1999) 495-500
80. Boman G., Backer U., Larsson S., Melander B., and Wahlander L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish society for pulmonary diseases. Eur J Respir Dis 64 (1983) 405-415
81. Black P.N., Morgan-Day A., McMillan T.E., Poole P.J., and Young R.P. Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. BMC Pulm Med 4 (2004) 13
82. Decramer M., Rutten-van Molken M., Dekhuijzen P.N., Troosters T., van Herwaarden C., Pellegrino R., et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (bronchitis randomized on NAC cost-utility study, BRONCUS): a randomised placebo-controlled trial. Lancet 365 (2005) 1552-1560
83. Jovanavic S., Steenken S., and Simic M. Reduction potentials of flavanoid and model phenoxyl radicals. J Chem Soc Perkin Trans 2 (1996) 2497-2503
84. Jovanavic S., Hara Y., Steenken S., and Simic M. Antioxidant potential of theaflavins. A pulse radiolysis study. J Am Chem Soc 119 (1997) 5337-5343
85. Cantin A.M., North S.L., Hubbard R.C., and Crystal R.G. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 63 (1987) 152-157
86. van der Vliet A., O'Neill C.A., Cross C.E., Koostra J.M., Volz W.G., Halliwell B., et al. Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids. Am J Physiol 276 (1999) L289-L296
87. Comhair S.A., Lewis M.J., Bhathena P.R., Hammel J.P., and Erzurum S.C. Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease. Am J Respir Crit Care Med 159 (1999) 1824-1829
88. Moodie F.M., Marwick J.A., Anderson C.S., Szulakowski P., Biswas S.K., Bauter M.R., et al. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappa B activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J 18 (2004) 1897-1899
89. Ito K., Ito M., Elliott W.M., Cosio B., Caramori G., Kon O.M., et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352 (2005) 1967-1976
90. Bridgeman M.M., Marsden M., Selby C., Morrison D., and MacNee W. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 49 (1994) 670-675
91. Cogdell R. The functions of pigments in chloroplasts (1988), Academic Press
92. Shi J., and Le Maguer M. Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit Rev Biotechnol 20 (2000) 293-334
93. Prince M.R., and Frisoli J.K. Beta-carotene accumulation in serum and skin. Am J Clin Nutr 57 (1993) 175-181
94. Stahl W., Schwarz W., von Laar J., and Sies H. All-trans beta-carotene preferentially accumulates in human chylomicrons and very low density lipoproteins compared with the 9-cis geometrical isomer. J Nutr 125 (1995) 2128-2133
95. Donnelly L.E., Newton R., Kennedy G.E., Fenwick P.S., Leung R.H., Ito K., et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 287 (2004) L774-L783
96. Wheeler D.S., Catravas J.D., Odoms K., Denenberg A., Malhotra V., and Wong H.R. Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells. J Nutr 134 (2004) 1039-1044
97. Walle T., Hsieh F., DeLegge M.H., Oatis Jr. J.E., and Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32 (2004) 1377-1382
98. Lu H., Meng X., Li C., Sang S., Patten C., Sheng S., et al. Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab Dispos 31 (2003) 452-461
99. Lambert J.D., Lee M.J., Lu H., Meng X., Hong J.J., Seril D.N., et al. Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J Nutr 133 (2003) 4172-4177
100. Chen L., Lee M.J., Li H., and Yang C.S. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos 25 (1997) 1045-1050
101. Hong J., Lambert J.D., Lee S.H., Sinko P.J., and Yang C.S. Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem Biophys Res Commun 310 (2003) 222-227
102. Burton G.W., Traber M.G., Acuff R.V., Walters D.N., Kayden H., Hughes L., et al. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am J Clin Nutr 67 (1998) 669-684
103. Rahman I., and MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol Lung Cell Mol Physiol 277 (1999) L1067-L1088
104. Tabak C., Smit H.A., Rasanen L., Fidanza F., Menotti A., Nissinen A., et al. Dietary factors and pulmonary function: a cross sectional study in middle aged men from three European countries. Thorax 54 (1999) 1021-1026
105. Foronjy R.F., Mirochnitchenko O., Propokenko O., Lemaitre V., Jia Y., Inouye M., et al. Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice. Am J Respir Crit Care Med 173 (2006) 623-631
106. Cuzzocrea S., McDonald M.C., Mazzon E., Filipe H.M., Centorrino T., Lepore V., et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit Care Med 29 (2001) 102-111
107. Zhu M., Chen Y., and Li R.C. Oral absorption and bioavailability of tea catechins. Planta Med 66 (2000) 444-447
108. Summers Q.A., Fleming J.S., Dai Y., Perring S., Honeywell R., Gough K.J., et al. The pulmonary deposition of two aerosol preparations of nedocromil sodium delivered by MDI assessed by single photon emission computed tomography. J Aerosol Med 9 Suppl. 1 (1996) S93-S109
109. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 2645-2653
110. Chan H.K., Daviskas E., Eberl S., Robinson M., Bautovich G., and Young I. Deposition of aqueous aerosol of technetium-99m diethylene triamine penta-acetic acid generated and delivered by a novel system (AERx) in healthy subjects. Eur J Nucl Med 26 (1999) 320-327
111. Jaimes E.A., DeMaster E.G., Tian R.X., and Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol 24 (2004) 1031-1036
112. Deliconstantinos G., and Villiotou V. Gas phase oxidants of cigarette smoke increase nitric oxide synthase and xanthine oxidase activities of rabbit brain synaptosomes. Neurochem Res 25 (2000) 769-774